Richmond Pharmacology

For profitWebsite ↗

Also known as: Richmond Phamacology, LTD | Richmond Pharmacology | Richmond Pharmacology Limited | Richmond Pharmacology Ltd CEO | Richmond Pharmacology Ltd St George's University of London Cranmer Terrace, TootingLondon SW17 ORE UK | Richmond Pharmacology Ltd, UK

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2006

Last known activity

Jun 20, 2024

Timeline

2000s

Jun 1, 2001
Richmond Pharmacology— Founded

Drugs by trial phase (52 distinct, 44 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

nitroglycerin

Phase 1 (48 own, 0 via acquisition)

Indications

Studied for

Recent trials (50)

NCT06480981OfficialPhase 1Jun 20, 2024
NCT06128954Overall official - principal investigatorPhase 1Jan 2, 2024
NCT06128954OfficialPhase 1Jan 2, 2024
NCT07014735Lead sponsorN/AApr 13, 2023
NCT05160363Overall official - principal investigatorPhase 1Jan 31, 2022
NCT05160363CollaboratorPhase 1Jan 31, 2022
NCT04866602Overall official - principal investigatorPhase 1Nov 30, 2021
NCT04866602CollaboratorPhase 1Nov 30, 2021
NCT04686669CollaboratorPhase 1Dec 31, 2020
NCT04686669Overall official - principal investigatorPhase 1Dec 31, 2020
NCT04065698Overall official - principal investigatorPhase 1Aug 13, 2019
NCT04032535Overall official - principal investigatorPhase 1Jul 23, 2019
NCT04045405Overall official - principal investigatorPhase 1Jun 21, 2019
NCT04002687Overall official - principal investigatorPhase 1Apr 4, 2019
NCT04002687CollaboratorPhase 1Apr 4, 2019

Details

Founded: London, GB Jun 1, 2001
Last known activity: Jun 20, 2024